STAT

NOVEMBER 21, 2023

They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United States, people with Asian ancestry are almost always grouped into a single racial category. Nearly 25 million Americans — from Hmong to Laotians, and Koreans to Indonesians — have been given the same label by the U.S. government despi

Labelling 350

Labelling 350

Pharmaceutical Technology

NOVEMBER 21, 2023

Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.

141

141

STAT

NOVEMBER 21, 2023

Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to get vaccinated, fulfilling a long-standing ambition of pharmacists to provide more expansive clinical services.

Vaccines 346

Vaccines 346

Pharma Times

NOVEMBER 21, 2023

SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes

137

137

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 21, 2023

Few people leave the world with as much grace or influence as Rosalynn Smith Carter, who died Sunday at the age of 96. While she called her autobiography “The First Lady of Plains,” to many she was also the first lady of mental health reform. Decades ago, she took bold stances on mental health topics that, today, have become conventional wisdom: Mental health is health, stigma is deadly, and people with mental illness deserve to be part of society instead of hidden away in overcrow

336

336

Pharma Times

NOVEMBER 21, 2023

Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes

131

131

BioPharma Dive

NOVEMBER 21, 2023

The partnership is another investment by the biotech subsidiary in artificial intelligence for drug discovery and development, continuing an industry trend.

130

130

STAT

NOVEMBER 21, 2023

WASHINGTON — It took nearly three weeks for a maker of eye drops to recall its products after the Food and Drug Administration requested a recall. There have been no reports of injuries, but some key lawmakers are arguing the time it took the FDA to coax a voluntary recall shows the agency should be given the power to force them. Eye drops must be sterile because drugs applied to eyes bypass some of the body’s natural defenses.

255

255

PharmaVoice

NOVEMBER 21, 2023

Connie Chang, COO at ONL Therapeutics, describes what it takes to bring a CEO’s vision to life.

130

130

STAT

NOVEMBER 21, 2023

If Paul Grand weren’t the CEO of MedTech Innovator, the largest medical device accelerator in the world, he might have been a keychain salesman. Maybe a producer of the X-Files. Or even invented Quizlet. The son of a teacher and a dentist, Grand graduated from selling neighbors keychains and washing cars as a little kid to programming software that made his parents’ lives easier.

250

250

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

European Pharmaceutical Review

NOVEMBER 21, 2023

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.

116

116

STAT

NOVEMBER 21, 2023

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.

Diabetes 210

Diabetes Immunity Immunization 210

pharmaphorum

NOVEMBER 21, 2023

New NICE Advice service Mike.

115

115

STAT

NOVEMBER 21, 2023

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug faltered in addressing patient symptoms, causing the company’s stock to fall in early Tuesday trading. In the Phase 3 trial, the German company was testing its drug candidate pelabresib combined with the drug Jakafi against a Jakafi-placebo duo in patients with newly diagnosed myelofibrosis, a type of rare blood cancer.

203

203

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 21, 2023

GSK says new inhaler will help slash its carbon footprint Phil.

115

115

STAT

NOVEMBER 21, 2023

Hello, everyone. Damian Garde here, filling in for Ed Silverman on what is an abbreviated work week here in the U.S., where the holiday discourse has pivoted from how to deal with quarrelsome relatives to whether a certain overexposed obesity treatment is ruining the apparently hallowed tradition of consuming more food than you need. If your personal geography spares you from all this, perhaps consider giving some thanks.

183

183

pharmaphorum

NOVEMBER 21, 2023

Digital measures for value-based healthcare: Current perspectives Mike.

114

114

STAT

NOVEMBER 21, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at an ambitious genomics startup, some cautious optimism on Wall Street, and a rough day for an American in Germany.

Drug Pricing 154

Drug Pricing Drug Development Vaccines 154

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

NOVEMBER 21, 2023

Studying somatic mutations could be “the next wave of opportunity” to develop more precise medicines, said Mike Stratton, one of Quotient’s scientific co-founders.

112

112

pharmaphorum

NOVEMBER 21, 2023

MSD reaches $610m deal to buy lysosome biotech Caraway Phil.

105

105

BioPharma Dive

NOVEMBER 21, 2023

Surging demand for GLP-1 agonists has put medtech firms like Medtronic under pressure, even as they argue the hit to their businesses will be minimal.

109

109

pharmaphorum

NOVEMBER 21, 2023

MorphoSys shrugs off mixed results for myelofibrosis drug Phil.

104

104

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Commerce

NOVEMBER 21, 2023

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

104

104

pharmaphorum

NOVEMBER 21, 2023

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.

Immunity 104

Immunity Immunization 104

European Pharmaceutical Review

NOVEMBER 21, 2023

BRUKINSA ® (zanubrutinib) in combination with the anti-CD20 monoclonal antibody obinutuzumab, has been approved by the European Commission (EC) to treat relapsed or refractory follicular lymphoma in individuals who have received at least two prior lines of systemic therapy. The oral treatment is now “the first Bruton’s tyrosine kinase (BTK) inhibitor approved in this indication and has the broadest label of any medicine in its class globally,” stated Dr Mehrdad Mobasher, Chief Medical Officer, H

Labelling 98

Labelling 98

pharmaphorum

NOVEMBER 21, 2023

Abecma delay gives Carvykti a chance to catch up Phil.

100

100

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Technology

NOVEMBER 21, 2023

The FDA's decision on the sBLA for Abecma will be delayed beyond the set PDUFA target date of 16 December.

98

98

pharmaphorum

NOVEMBER 21, 2023

Oxurion files for bankruptcy as DME drug fails Phil.

98

98

Pharmaceutical Technology

NOVEMBER 21, 2023

The new scheme will launch in 2024 and aims to save the National Health Service (NHS) £14bn over five years.

98

98

pharmaphorum

NOVEMBER 21, 2023

Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform Phil.

96

96

World Pharma News

NOVEMBER 21, 2023

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Application for XTANDI® (enzalutamide), following FDA expedited development and review programs (Priority Review designation, Fast Track designation, Real-time Oncology Review), based on results from the Phase 3 EMBARK trial.

91

91